Postgraduate Institute for Medicine

Ace the Case: Disease Progression in a 72-Year-Old Woman With Chronic Lymphocytic Leukemia Previously Treated With Venetoclax-Obinutuzumab

Overview / Abstract:	This activity utilizes a case study to discuss treatment options for an older patient with relapsed chronic lymphocytic leukemia (CLL).
Expiration	Feb 23, 2023
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME
Format	Online
Credits / Hours	0.5
Accreditation	ACCME; ABIM MOC Part 2
Presenters / Authors / Faculty	Chaitra S. Ujjani, MD Associate Professor University of Washington/Fred Hutchinson Cancer Research Center Seattle, Washington
Activity Specialities / Related Topics	Hematology, Education / Teaching, Cardiology / Cardiovascular, Oncology / Cancer / Radiation Therapy
Sponsors / Supporters / Grant Providers	This activity is supported by independent educational grants from AstraZeneca; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and TG Therapeutics, Inc.
Keywords / Search Terms	RedMedEd RedMedEd, Web-based, Technology, Online, CME, Free, Free CE, Free CME, RedMedEd, Patient case, Chronic Lymphocytic Leukemia, CLL, older patient; relapsed; chronic lymphocytic leukemia; hematologists; oncologists, safety; agents, novel, treat, treatment, adjustments, current, emerging, data, adverse events, durable response, disease progression Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map